| scholarly article | Q13442814 |
| P2093 | author name string | Alexander Dömling | |
| Philip H Elsinga | |||
| Tobias Ritter | |||
| Gonçalo S Clemente | |||
| Tryfon Zarganes-Tzitzikas | |||
| Inês F Antunes | |||
| Jens Rickmeier | |||
| P2860 | cites work | The 3-hydroxy-3-methylglutaryl coenzyme-A (HMG-CoA) reductases | Q21194859 |
| Lipid-lowering efficacy of atorvastatin | Q24187301 | ||
| Heavy snoring as a cause of carotid artery atherosclerosis | Q24647982 | ||
| Statins for the prevention and treatment of acute lung injury and acute respiratory distress syndrome: A systematic review and meta-analysis | Q26746082 | ||
| Macrophage-mediated cholesterol handling in atherosclerosis | Q26780405 | ||
| Role of Helicobacter pylori infection in pathogenesis of atherosclerosis | Q27002402 | ||
| Structural mechanism for statin inhibition of HMG-CoA reductase | Q27631717 | ||
| 3-Hydroxy-3-methylglutaryl-coenzyme A reductase activity is inhibited by cholesterol and up-regulated by sitosterol in sitosterolemic fibroblasts | Q28371917 | ||
| Immunity, atherosclerosis and cardiovascular disease | Q28688590 | ||
| A historical perspective on the discovery of statins | Q34022421 | ||
| Statins and breast cancer prognosis: evidence and opportunities. | Q34206487 | ||
| Dietary cholesterol and cardiovascular disease: a systematic review and meta-analysis | Q34482286 | ||
| Role of Nrf2 in the pathogenesis of atherosclerosis | Q34482582 | ||
| Systemic lupus erythematosus and atherosclerosis: Review of the literature | Q34490659 | ||
| Total cholesterol as a risk factor for coronary heart disease and stroke in women compared with men: A systematic review and meta-analysis. | Q34519956 | ||
| Mevalonate pathway: a review of clinical and therapeutical implications | Q34623889 | ||
| The effects of statins on blood pressure: current knowledge and future perspectives | Q35843899 | ||
| Statins as anti-inflammatory agents in atherogenesis: molecular mechanisms and lessons from the recent clinical trials. | Q36088110 | ||
| Current use of statins reduces risk of HIV rebound on suppressive HAART | Q36294013 | ||
| Global, Regional, and National Burden of Cardiovascular Diseases for 10 Causes, 1990 to 2015. | Q36376945 | ||
| Familial hypercholesterolemia and the atherosclerotic disease | Q37029808 | ||
| Feedback regulation of cholesterol synthesis: sterol-accelerated ubiquitination and degradation of HMG CoA reductase | Q37173755 | ||
| Early Statin Use and the Progression of Alzheimer Disease: A Total Population-Based Case-Control Study | Q37328707 | ||
| 3-Hydroxy-3-methylglutaryl-coenzyme A reductase is present in peroxisomes in normal rat liver cells | Q37676690 | ||
| Perivascular adipose tissue as a cause of atherosclerosis. | Q37774439 | ||
| Infectious causes of atherosclerosis | Q37879248 | ||
| Hydrogen sulfide and the pathogenesis of atherosclerosis | Q38098634 | ||
| Novel prospects of statins as therapeutic agents in cancer | Q38227813 | ||
| Homocysteine and the pathogenesis of atherosclerosis | Q38344699 | ||
| The effect of statins on cancer cells--review | Q38499265 | ||
| Interplay between CRP, Atherogenic LDL, and LOX-1 and Its Potential Role in the Pathogenesis of Atherosclerosis. | Q38647831 | ||
| Clinical Studies of Statins in Asthma and COPD. | Q38694007 | ||
| The anti‑dengue virus properties of statins may be associated with alterations in the cellular antiviral profile expression | Q38757254 | ||
| The central role of arterial retention of cholesterol-rich apolipoprotein-B-containing lipoproteins in the pathogenesis of atherosclerosis: a triumph of simplicity | Q38912473 | ||
| Pleiotropic Effects of Statins on the Cardiovascular System | Q39069187 | ||
| Roles of Vascular Oxidative Stress and Nitric Oxide in the Pathogenesis of Atherosclerosis. | Q39139744 | ||
| Hypercholesterolemia As a Risk Factor for Cardiovascular Disease: Current Controversial Therapeutic Management | Q39163156 | ||
| The beneficial effects of HMG-CoA reductase inhibitors in the processes of neurodegeneration. | Q39348762 | ||
| Statins in hypertension: are they a new class of antihypertensive agents? | Q39928628 | ||
| Prenylation of viral proteins by enzymes of the host: Virus-driven rationale for therapy with statins and FT/GGT1 inhibitors | Q40039988 | ||
| The oxidation hypothesis of atherosclerosis | Q40625668 | ||
| The iron hypothesis--does iron cause atherosclerosis? | Q41259409 | ||
| Association Between Statin Use and Endometrial Cancer Survival | Q41515925 | ||
| Effect of atorvastatin on memory in albino mice | Q41589216 | ||
| 18F-Deoxyfluorination of Phenols via Ru π-Complexes | Q41764286 | ||
| Are statins a viable option for the treatment of infections with the hepatitis C virus? | Q42224808 | ||
| HDAC6 Brain Mapping with [18F]Bavarostat Enabled by a Ru-Mediated Deoxyfluorination | Q42367165 | ||
| Statins May Decrease the Fatality Rate of Middle East Respiratory Syndrome Infection | Q42671754 | ||
| Expression of HMG-CoA reductase in human coronary atherosclerotic plaques and relationship to plaque destabilisation | Q44245889 | ||
| Hepatic HMG-CoA reductase expression and resistance to dietary cholesterol. | Q44851170 | ||
| Binding thermodynamics of statins to HMG-CoA reductase | Q46674816 | ||
| Statins in the treatment of COPD and asthma-where do we stand? | Q50045046 | ||
| Apolipoprotein E-deficient rats develop atherosclerotic plaques in partially ligated carotid arteries. | Q50278698 | ||
| Atorvastatin dose-dependently promotes mouse lung repair after emphysema induced by elastase. | Q51733034 | ||
| Liver and statins: a critical appraisal of the evidence. | Q52626068 | ||
| Neuroprotective effects of statins against amyloid β-induced neurotoxicity. | Q52689881 | ||
| Statins Suppress Ebola Virus Infectivity by Interfering with Glycoprotein Processing. | Q52714949 | ||
| Statins: a role in breast cancer therapy? | Q57105348 | ||
| Site-Specific Deoxyfluorination of Small Peptides with [ F]Fluoride | Q57800896 | ||
| Atorvastatin (Lipitor) by MCR | Q64268342 | ||
| Pleiotropic Effects of Statins: Untapped Potential for Statin Pharmacotherapy | Q64864761 | ||
| The oxidative stress hypothesis of atherosclerosis: cause or product? | Q73477025 | ||
| Functional analysis of the hepatic HMG-CoA reductase promoter by in vivo electroporation | Q79843219 | ||
| Preface to volume 35 | Q83791562 | ||
| Differences in statin associated neuroprotection corresponds with either decreased production of IL-1β or TNF-α in an in vitro model of neuroinflammation-induced neurodegeneration | Q88011769 | ||
| Atherosclerosis: integration of its pathogenesis as a self-perpetuating propagating inflammation: a review | Q90538050 | ||
| P433 | issue | 1 | |
| P304 | page(s) | 34 | |
| P577 | publication date | 2020-04-15 | |
| P1433 | published in | EJNMMI Research | Q27723773 |
| P1476 | title | [18F]Atorvastatin: synthesis of a potential molecular imaging tool for the assessment of statin-related mechanisms of action | |
| P478 | volume | 10 |
Search more.